New study co-led by OHSU researchers provides most robust U.S. estimate to date, shows overdiagnosis not as ‘alarmingly frequent’ as commonly believed.
W. M. Keck Foundation awards OHSU research duo $1 million to develop new technology to quantify molecular aggregates, track their involvement in cellular functions, disease.